1 Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma Mar 24, 2025
3 Angry FDA & CDC: $5 Billion Bivalent Moderna New Crown Vaccine Not As Effective As Monovalent Mar 16, 2025
4 Good News, Orphan Drug Status Granted By The FDA For Ezurpimtrostat, a Cutting Edge Drug For Liver Cancer! Mar 10, 2025
6 New Targeted Drug For Leukaemia Approved, 35% Of Patients' Cancer Cells Disappear Completely! Feb 06, 2025
Read More Apparatus World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us Apr 02, 2025
Read More Medical Three-drug Combination For HPV-positive Cancers Results In Significant Tumour Shrinkage In 88% Of Patients! Mar 15, 2025
Read More Apparatus Angry FDA & CDC: $5 Billion Bivalent Moderna New Crown Vaccine Not As Effective As Monovalent Mar 16, 2025
Read More Medical More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy! Apr 04, 2025
